# Pioneer Power Solutions, Inc.: financial statements, quarterly

PPSI · Nasdaq · CIK 1449792 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ppsi.md) · [Financials](/companies/ppsi/financials.md) · [Filings](/companies/ppsi/filings.md) · [Insiders](/companies/ppsi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ppsi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.5](/filings/0001493152-24-045402.md) | [(22.2) d](/filings/0001641172-25-004681.md) | [3.3](/filings/0001641172-25-011072.md) | [3.4](/filings/0001641172-25-023969.md) | [6.4](/filings/0001493152-25-023644.md) | [9.8 d](/filings/0001493152-26-015715.md) | [6.7](/filings/0001493152-26-023939.md) | [8.4](/filings/0001493152-26-038515.md) | [6.9](/filings/0001493152-25-023644.md) | [5.6 d](/filings/0001493152-26-015715.md) | [4.3](/filings/0001493152-26-023939.md) | [5.0](/filings/0001493152-26-038515.md) |
| Cost of revenue | $m | [7.8](/filings/0001493152-24-045402.md) | [(14.0) d](/filings/0001641172-25-004681.md) | [2.8](/filings/0001641172-25-011072.md) | [2.8](/filings/0001641172-25-023969.md) | [4.9](/filings/0001493152-25-023644.md) | [6.9 d](/filings/0001493152-26-015715.md) | [6.6](/filings/0001493152-26-023939.md) | [7.1](/filings/0001493152-26-038515.md) | [6.2](/filings/0001493152-25-023644.md) | [4.3 d](/filings/0001493152-26-015715.md) | [3.7](/filings/0001493152-26-023939.md) | [4.0](/filings/0001493152-26-038515.md) |
| Gross profit | $m | [3.7](/filings/0001493152-24-045402.md) | [(8.2) d](/filings/0001641172-25-004681.md) | [0.5](/filings/0001641172-25-011072.md) | [0.6](/filings/0001641172-25-023969.md) | [1.5](/filings/0001493152-25-023644.md) | [2.8 d](/filings/0001493152-26-015715.md) | [0.1](/filings/0001493152-26-023939.md) | [1.3](/filings/0001493152-26-038515.md) | [0.6](/filings/0001493152-25-023644.md) | [1.3 d](/filings/0001493152-26-015715.md) | [0.6](/filings/0001493152-26-023939.md) | [1.0](/filings/0001493152-26-038515.md) |
| Research and development | $m | not reported | not reported | [0.2](/filings/0001641172-25-011072.md) | [0.2](/filings/0001641172-25-023969.md) | [0.3](/filings/0001493152-25-023644.md) | [0.3 d](/filings/0001493152-26-015715.md) | [0.1](/filings/0001493152-26-023939.md) | [0.5](/filings/0001493152-26-038515.md) | [0.1](/filings/0001493152-25-023644.md) | [0.1 d](/filings/0001493152-26-015715.md) | [0.2](/filings/0001493152-26-023939.md) | [0.2](/filings/0001493152-26-038515.md) |
| Selling, general and administrative | $m | [2.8](/filings/0001493152-24-045402.md) | [0.4 d](/filings/0001641172-25-004681.md) | [2.1](/filings/0001641172-25-011072.md) | [2.1](/filings/0001641172-25-023969.md) | [2.0](/filings/0001493152-25-023644.md) | [3.5 d](/filings/0001493152-26-015715.md) | [2.4](/filings/0001493152-26-023939.md) | [2.5](/filings/0001493152-26-038515.md) | [2.0](/filings/0001493152-25-023644.md) | [2.3 d](/filings/0001493152-26-015715.md) | [2.4](/filings/0001493152-26-023939.md) | [2.8](/filings/0001493152-26-038515.md) |
| Operating income | $m | [0.9](/filings/0001493152-24-045402.md) | [(9.4) d](/filings/0001641172-25-004681.md) | [(1.7)](/filings/0001641172-25-011072.md) | [(1.7)](/filings/0001641172-25-023969.md) | [(0.7)](/filings/0001493152-25-023644.md) | [(1.1) d](/filings/0001493152-26-015715.md) | [(2.3)](/filings/0001493152-26-023939.md) | [(1.7)](/filings/0001493152-26-038515.md) | [(1.4)](/filings/0001493152-25-023644.md) | [(1.1) d](/filings/0001493152-26-015715.md) | [(2.0)](/filings/0001493152-26-023939.md) | [(2.0)](/filings/0001493152-26-038515.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-25-023644.md) | [0.0 d](/filings/0001493152-26-015715.md) | not reported | not reported |
| Net income | $m | [1.0](/filings/0001493152-24-045402.md) | [(4.5) d](/filings/0001641172-25-004681.md) | [(1.0)](/filings/0001641172-25-011072.md) | [(2.3)](/filings/0001641172-25-023969.md) | [(1.1)](/filings/0001493152-25-023644.md) | [36.3 d](/filings/0001493152-26-015715.md) | [(0.9)](/filings/0001493152-26-023939.md) | [(1.3)](/filings/0001493152-26-038515.md) | [(2.4)](/filings/0001493152-25-023644.md) | [(1.4) d](/filings/0001493152-26-015715.md) | [(2.5)](/filings/0001493152-26-023939.md) | [(2.1)](/filings/0001493152-26-038515.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001493152-24-045402.md) | not reported | [(0.10)](/filings/0001641172-25-011072.md) | [(0.21)](/filings/0001641172-25-023969.md) | [(0.10)](/filings/0001493152-25-023644.md) | not reported | [(0.09)](/filings/0001493152-26-023939.md) | [(0.12)](/filings/0001493152-26-038515.md) | [(0.21)](/filings/0001493152-25-023644.md) | not reported | [(0.23)](/filings/0001493152-26-023939.md) | [(0.19)](/filings/0001493152-26-038515.md) |
| Basic EPS | $ per share | [0.10](/filings/0001493152-24-045402.md) | not reported | [(0.10)](/filings/0001641172-25-011072.md) | [(0.21)](/filings/0001641172-25-023969.md) | [(0.10)](/filings/0001493152-25-023644.md) | not reported | [(0.09)](/filings/0001493152-26-023939.md) | [(0.12)](/filings/0001493152-26-038515.md) | [(0.21)](/filings/0001493152-25-023644.md) | not reported | [(0.23)](/filings/0001493152-26-023939.md) | [(0.19)](/filings/0001493152-26-038515.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.6](/filings/0001493152-23-041076.md) | [3.6](/filings/0001493152-24-029269.md) | [6.2](/filings/0001493152-24-035661.md) | [6.5](/filings/0001493152-24-040481.md) | [3.1](/filings/0001493152-24-045402.md) | [41.6](/filings/0001641172-25-004681.md) | [25.8](/filings/0001641172-25-011072.md) | [18.0](/filings/0001641172-25-023969.md) | [17.3](/filings/0001493152-25-023644.md) | [15.0](/filings/0001493152-26-038515.md) | [13.6](/filings/0001493152-26-023939.md) | [10.7](/filings/0001493152-26-038515.md) |
| Current assets | $m | [30.3](/filings/0001493152-24-029269.md) | [27.7](/filings/0001641172-25-004681.md) | [34.3](/filings/0001493152-24-035661.md) | [33.0](/filings/0001493152-24-040481.md) | [31.5](/filings/0001493152-24-045402.md) | [56.7](/filings/0001493152-26-015715.md) | [38.6](/filings/0001641172-25-011072.md) | [29.3](/filings/0001641172-25-023969.md) | [29.0](/filings/0001493152-25-023644.md) | [25.5](/filings/0001493152-26-038515.md) | [23.7](/filings/0001493152-26-023939.md) | [22.6](/filings/0001493152-26-038515.md) |
| Total assets | $m | [35.7](/filings/0001493152-24-029269.md) | [33.0](/filings/0001641172-25-004681.md) | [39.3](/filings/0001493152-24-035661.md) | [38.0](/filings/0001493152-24-040481.md) | [40.1](/filings/0001493152-24-045402.md) | [66.0](/filings/0001493152-26-015715.md) | [47.5](/filings/0001641172-25-011072.md) | [39.1](/filings/0001641172-25-023969.md) | [37.6](/filings/0001493152-25-023644.md) | [35.5](/filings/0001493152-26-038515.md) | [33.0](/filings/0001493152-26-023939.md) | [31.5](/filings/0001493152-26-038515.md) |
| Current liabilities | $m | [16.6](/filings/0001493152-24-029269.md) | [18.3](/filings/0001641172-25-004681.md) | [20.8](/filings/0001493152-24-035661.md) | [21.9](/filings/0001493152-24-040481.md) | [22.4](/filings/0001493152-24-045402.md) | [30.0](/filings/0001493152-26-015715.md) | [12.5](/filings/0001641172-25-011072.md) | [5.4](/filings/0001641172-25-023969.md) | [6.3](/filings/0001493152-25-023644.md) | [4.9](/filings/0001493152-26-038515.md) | [5.1](/filings/0001493152-26-023939.md) | [5.5](/filings/0001493152-26-038515.md) |
| Total liabilities | $m | [17.2](/filings/0001493152-24-029269.md) | [18.8](/filings/0001641172-25-004681.md) | [21.2](/filings/0001493152-24-035661.md) | [22.2](/filings/0001493152-24-040481.md) | [25.4](/filings/0001493152-24-045402.md) | [30.5](/filings/0001493152-26-015715.md) | [13.0](/filings/0001641172-25-011072.md) | [6.1](/filings/0001641172-25-023969.md) | [6.9](/filings/0001493152-25-023644.md) | [6.1](/filings/0001493152-26-038515.md) | [6.2](/filings/0001493152-26-023939.md) | [6.8](/filings/0001493152-26-038515.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [18.5](/filings/0001493152-24-045402.md) | [14.2](/filings/0001493152-26-015715.md) | [18.1](/filings/0001641172-25-023969.md) | [15.8](/filings/0001493152-25-023644.md) | [14.7](/filings/0001493152-25-023644.md) | [35.4](/filings/0001493152-26-038515.md) | [34.5](/filings/0001493152-26-038515.md) | [33.0](/filings/0001493152-26-038515.md) | [30.7](/filings/0001493152-25-023644.md) | [29.3](/filings/0001493152-26-038515.md) | [26.8](/filings/0001493152-26-038515.md) | [24.8](/filings/0001493152-26-038515.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.6) d](/filings/0001493152-24-045402.md) | [(3.7) d](/filings/0001641172-25-004681.md) | [(2.0)](/filings/0001641172-25-011072.md) | [0.6 d](/filings/0001641172-25-023969.md) | [(2.7) d](/filings/0001493152-25-023644.md) | [(2.1) d](/filings/0001493152-26-015715.md) | [1.5](/filings/0001493152-26-023939.md) | [(5.5) d](/filings/0001493152-26-038515.md) | [(0.8) d](/filings/0001493152-25-023644.md) | [(1.0) d](/filings/0001493152-26-015715.md) | [(0.9)](/filings/0001493152-26-023939.md) | [(2.7) d](/filings/0001493152-26-038515.md) |
| Capital expenditure | $m | [1.5 d](/filings/0001493152-24-045402.md) | [0.2 d](/filings/0001641172-25-004681.md) | [0.2](/filings/0001641172-25-011072.md) | [0.4 d](/filings/0001641172-25-023969.md) | [0.7 d](/filings/0001493152-25-023644.md) | [2.5 d](/filings/0001493152-26-015715.md) | [0.6](/filings/0001493152-26-023939.md) | [0.1 d](/filings/0001493152-26-038515.md) | [0.8 d](/filings/0001493152-25-023644.md) | [1.1 d](/filings/0001493152-26-015715.md) | [0.2](/filings/0001493152-26-023939.md) | [0.1 d](/filings/0001493152-26-038515.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | [16.7](/filings/0001493152-26-023939.md) | [0.0 d](/filings/0001493152-26-038515.md) | [0.0 d](/filings/0001493152-25-023644.md) | [0.0 d](/filings/0001493152-26-015715.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001493152-24-029269.md) | [9.8](/filings/0001493152-24-035661.md) | [10.7](/filings/0001493152-24-040481.md) | [10.3](/filings/0001493152-24-045402.md) | [10.3](/filings/0001641172-25-011072.md) | [10.9](/filings/0001641172-25-023969.md) | [10.9](/filings/0001493152-25-023644.md) | [11.2](/filings/0001493152-26-023939.md) | [11.1](/filings/0001493152-26-038515.md) | [11.1](/filings/0001493152-25-023644.md) | [11.1](/filings/0001493152-26-023939.md) | [11.1](/filings/0001493152-26-038515.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,099,266 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038515.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.